Omzo vs Pallas Health: Clinician-Guided Compounded Semaglutide Plans
When comparing Omzo vs Pallas Health, both connect patients with U.S. licensed clinicians for GLP-1 care and offer compounded semaglutide, but they differ on pricing structure, medication routing, and what the plan price includes. Early verdict: choose Pallas for a lower introductory month and bundled provider care; choose Omzo if you want a clinician-guided platform that emphasizes compounded options starting at $179.
Explore Omzo clinician-guided plans
Three key differences at a glance
This comparison focuses on the most distinctive supported differences: pricing and renewal structure, medication options and how providers deliver care, and shipping plus program inclusions and exclusions. Both providers note that compounded medications are not FDA approved.
Pricing and renewal structure
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279, presented as personalized compounded options. Pallas Health states compounded semaglutide is $139 for the first month, then $597 every 12 weeks, which Pallas represents as a $199 per month average. Pallas explicitly describes an intro month price followed by a renewal every 12 weeks for compounded plans. Omzo provides starting prices but captured evidence does not supply the exact renewal cadence or multiweek billing detail that Pallas documents.
See Pallas first-month pricing and plan details
Medication options and clinician role
Both programs use U.S. licensed clinicians to review eligibility and personalize treatment. Omzo emphasizes a Compounded Medication Program as its primary offering and notes its platform connects you with licensed providers who may prescribe compounded medications prepared by a state licensed sterile compounding pharmacy. Omzo also says providers may write prescriptions for branded medications but Omzo does not sell or ship branded drugs.
Pallas Health offers both routes from one intake: FDA approved brand-name GLP-1s such as Wegovy, Ozempic, Zepbound and Mounjaro and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas states the clinician will choose brand or compounded medicine as appropriate.
What the plan price includes and operational differences
Pallas advertises an all-in plan price that includes provider care, ongoing check-ins, and messaging with no separate membership fee. Pallas also highlights features like a self-serve portal, refunded in full if a clinician decides treatment is not right for you, and that most states do not require a video visit. Pallas is cash pay only and notes FSA HSA use may require a Letter of Medical Necessity.
Omzo frames its service as clinician guided and reviewed by licensed U.S. providers. Captured language clarifies Omzo is not a medical practice and clinical services are provided by third party networks of U.S. licensed clinicians who determine eligibility and make final prescribing decisions. Omzo states that compounded medications offered are produced in FDA registered facilities but are not FDA approved.
Check Omzo medication options and policies
Shipping, compounding, and regulatory notes
Pallas advertises free expedited and discreet shipping on every plan and that compounded medications are prepared in the USA by U.S. licensed compounding pharmacies. Omzo highlights fast, discreet delivery and that its compounded drugs are prepared by state licensed sterile compounding pharmacies. Both providers include the regulatory caution that compounded medications are not FDA approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Comparison table
| Criteria | Omzo | Pallas Health |
|---|---|---|
| Starting semaglutide price | $179 starting | $139 first month; $199/mo average |
| Tirzepatide starting price | $279 starting | $179 first month; $299/mo average |
| Brand-name option | Provider may prescribe branded meds; Omzo does not sell or ship branded drugs | Offers FDA approved brand-name GLP-1s and compounded options |
| Provider care included | Clinician-guided plans reviewed by licensed U.S. providers via platform connections | Provider care, check-ins and messaging included in plan price; no membership fee |
| Shipping and compounding | Fast, discreet delivery; compounded in state licensed sterile compounding pharmacy | Free expedited discreet shipping; compounded in the USA by licensed pharmacies |
| Regulatory note | Compounded medications are not FDA approved | Compounded medications are not FDA approved |
Start Pallas intake and pricing
Final thoughts on Omzo vs Pallas Health
Omzo and Pallas Health both connect patients to U.S. licensed clinicians and offer compounded semaglutide, but Pallas emphasizes a lower introductory price, bundled provider care, and the option for brand-name pens chosen during intake. Omzo emphasizes clinician-guided compounded programs with stated starting prices and clarifies that it connects users to a network of licensed clinicians rather than operating as a medical practice.
Choose Pallas Health if you want a lower first-month price, provider care included in the plan price, and the option for brand-name or compounded GLP-1s chosen by a clinician.
Choose Omzo if you prefer Omzo s clinician-guided compounded semaglutide program with listed starting prices and clinician review through third party licensed providers.